The Relationship Between Plasma C-Reactive Protein Levels and Presence and Severity of Coronary Stenosis in Patients With Stable Angina

Abstract

High-sensitivity C-reactive protein (hsCRP) is an inflammation marker and potential predictor of cardiovascular events. However, there is no consensus on the relationship between plasma hsCRP levels and angiographically documented severe coronary lesions in patients with stable angina pectoris. In this study we aimed to assess whether plasma levels of hsCRP can indicate the severity of the coronary artery disease (CAD) in patients with stable angina. A total of 52 subjects, who had undergone coronary angiography were divided into two groups as follows: those with stable angina (group 1, at least one coronary arteries stenosis >50%, n = 26) and normal (group 2, n = 26). Severity of CAD was evaluated by using the Gensini score index. For each group, the levels of hsCRP were measured. HsCRP levels were compared in the subjects with normal coronary arteries, and in those with one-, two-, and three-vessel CAD, and no significant differences among the groups were found (analysis of variance, p>0.05). There was no significant correlation between hsCRP levels and Gensini score index (r = 0.278, p = 0.169). We conclude that there is no relationship between hsCRP levels and the presence and severity of CAD in patients with stable angina.

Get full access to this article

View all access options for this article.

References

Ross R. : Atherosclerosis, an inflammatory disease. N Engl J Med 340:115-126, 2004.

Libby P. , Ridker PM , Maseri A. : Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002.

Ridker PM : High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813-1818, 2001.

Yudkin JS , Stehouwer CD , Emeis JJ , et al: C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978, 1999.

Liuzzo G. , Biasucci LM , Gallamore JR , et al: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331:417-424, 1994.

Avanzas P. , Arroyo-Espliguero R. , Cosin-Sales J. , et al: Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90:847-852, 2004.

Anderson JL , Carlquist JF , Muhlestein JB , et al: Evaluation of C-reactive protein, an inflammatory marker, and infection serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32:35-41, 1998.

Turkoglu EI , Gurgun C. , Zoghi M. , et al: The relationship between serum C-reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise test. Anadolu Kardiyol Derg 4:199-202, 2004.

Taniguchi H. , Momiyama Y. , Ohmori R. , et al: Association of plasma levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 178:173-177, 2005.

10.

Haidari M. , Javadi E. , Sadeghi B. , et al: Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem 33:309-315, 2001.

11.

Veselka J. , Prochazkova S. , Duchonova R. , et al: Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 13:151-154, 2002.

12.

Azar RR , Aoun G. , Fram DB , et al: Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise test . Am J Cardiol 86:205-207, 2000.

13.

Gensini GG A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606, 1983.

14.

Ridker PM , Buring JE , Shih J. , et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731-733, 1998.

15.

Heinrich J. , Schulte H. , Schonfeld R. , et al: Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 73:374-378, 1995.

16.

Haverkate F. , Thompson SG , Pyke SD , et al: Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462-466, 1997.

17.

Toss H. , Lindahl B. , Siegbahn A. , et al: Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96:4204-4210, 1997.

18.

Rebuzzi AG , Quaranta G. , Liuzzo G. , et al: Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris . Am J Cardiol 82:715-719, 1998.

19.

Auer J. , Berent R. , Lassnig E. , et al: C-reactive protein and coronary artery disease. Jpn Heart J 43:607-619, 2002.

20.

Hoffmeister A. , Rothenbacher D. , Bazner U. , et al: Role of markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 87:262-266, 2001.

21.

Garcia-Moll X. , Zouridakis E. , Cole D. , et al: C-reactive protein in patients with chronic stable angina: Differences in baseline serum concentration between women and men. Eur Heart J 21:1598-1606, 2000.

22.

Avanzas P. , Arroyo-Espliguero R. , Cosin-Sales J. , et al: Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175:151-157, 2004.

23.

Ridker PM , Hennekens CH , Rifai N. , et al: Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100:713-716, 1999.

24.

Ridker PM , Cushman M. , Stampfer MJ , et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997.

25.

Horne BD , Muhlestein JB , Carlquist JF , et al: Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol 36:1774-1780, 2000 .

26.

Ridker PM , Rifai N. , Clearfield M. , et al: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344:1959-1965, 2001.